Anyone with metabolic, cardiac, GI, hepatic, or renal disease or who is pregnant, breastfeeding, or planning pregnancy should not consider it without licensed clinical care
Nitric Oxide System Modulation BPC-157 interacts significantly with the nitric oxide (NO) system, upregulating nitric oxide synthase (NOS) gene and protein expression while increasing nitric oxide production
If you miss a dose, contact your doctor to establish a new dosing schedule
Glucose 6-phosphate dehydrogenase from human erythrocytes
In the STEP and SURMOUNT trials for semaglutide and tirzepatide respectively, weight loss curves generally began to flatten between weeks 36 and 60, reflecting the physiological set point adaptation that occurs as appetite suppression becomes partially offset by metabolic adaptation
Research into BPC 157 is ongoing, and more studies focusing specifically on dogs are needed to fully understand the range of benefits it may have to offer